AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA
Authors: CLIFT RA BUCKNER CD
Citation: Ra. Clift et Cd. Buckner, MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA, Cancer investigation, 16(1), 1998, pp. 53-61
BONE-MARROW TRANSPLANTS FROM UNRELATED DONORS FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA
Authors: HANSEN JA GOOLEY TA MARTIN PJ APPELBAUM F CHAUNCEY TR CLIFT RA PETERSDORF EW RADICH J SANDERS JE STORB RF SULLIVAN KM ANASETTI C
Citation: Ja. Hansen et al., BONE-MARROW TRANSPLANTS FROM UNRELATED DONORS FOR PATIENTS WITH CHRONIC MYELOID-LEUKEMIA, The New England journal of medicine, 338(14), 1998, pp. 962-968
LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL OF 2 IRRADIATION REGIMENS FOR PATIENTS RECEIVING ALLOGENEIC MARROW TRANSPLANTS DURING FIRST REMISSION OF ACUTE MYELOID-LEUKEMIA
Authors: CLIFT RA BUCKNER CD APPELBAUM FR SULLIVAN KM STORB R THOMAS ED
Citation: Ra. Clift et al., LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL OF 2 IRRADIATION REGIMENS FOR PATIENTS RECEIVING ALLOGENEIC MARROW TRANSPLANTS DURING FIRST REMISSION OF ACUTE MYELOID-LEUKEMIA, Blood, 92(4), 1998, pp. 1455-1456
ALLOGRAFTING FOR CHRONIC MYELOID-LEUKEMIA
Authors: CLIFT RA ANASETTI C
Citation: Ra. Clift et C. Anasetti, ALLOGRAFTING FOR CHRONIC MYELOID-LEUKEMIA, Bailliere's clinical haematology, 10(2), 1997, pp. 319-336
MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE INFLUENCE OF PLASMA BUSULFAN LEVELS ON THE OUTCOME OF TRANSPLANTATION
Authors: SLATTERY JT CLIFT RA BUCKNER CD RADICH J STORER B BENSINGER WI SOLL E ANASETTI C BOWDEN R BRYANT E CHAUNCEY T DEEG HJ DONEY KC FLOWERS M GOOLEY T HANSEN JA MARTIN PJ MCDONALD GB NASH R PETERSDORF EW SANDERS JE SCHOCH G STEWART P STORB R SULLIVAN KM THOMAS ED WITHERSPOON RP APPELBAUM FR
Citation: Jt. Slattery et al., MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - THE INFLUENCE OF PLASMA BUSULFAN LEVELS ON THE OUTCOME OF TRANSPLANTATION, Blood, 89(8), 1997, pp. 3055-3060
STEM-CELL TRANSPLANTATION FOR SECONDARY ACUTE MYELOID-LEUKEMIA - EVALUATION OF TRANSPLANTATION AS INITIAL THERAPY OR FOLLOWING INDUCTION CHEMOTHERAPY
Authors: ANDERSON JE GOOLEY TA SCHOCH G ANASETTI C BENSINGER WI CLIFT RA HANSEN JA SANDERS JE STORB R APPELBAUM FR
Citation: Je. Anderson et al., STEM-CELL TRANSPLANTATION FOR SECONDARY ACUTE MYELOID-LEUKEMIA - EVALUATION OF TRANSPLANTATION AS INITIAL THERAPY OR FOLLOWING INDUCTION CHEMOTHERAPY, Blood, 89(7), 1997, pp. 2578-2585
LONG-TERM FOLLOW-UP OF ALLOGENEIC MARROW TRANSPLANTS IN PATIENTS WITHAPLASTIC-ANEMIA CONDITIONED BY CYCLOPHOSPHAMIDE COMBINED WITH ANTITHYMOCYTE GLOBULIN
Authors: STORB R LEISENRING W ANASETTI C APPELBAUM FR BUCKNER CD BENSINGER WI CHAUNCEY T CLIFT RA DEEG HJ DONEY KC FLOWERS MED HANSEN JA MARTIN PJ SANDERS KM WITHERSPOON RP
Citation: R. Storb et al., LONG-TERM FOLLOW-UP OF ALLOGENEIC MARROW TRANSPLANTS IN PATIENTS WITHAPLASTIC-ANEMIA CONDITIONED BY CYCLOPHOSPHAMIDE COMBINED WITH ANTITHYMOCYTE GLOBULIN, Blood, 89(10), 1997, pp. 3890-3891
TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS MOBILIZED BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: BENSINGER WI CLIFT RA ANASETTI C APPELBAUM FA DEMIRER T ROWLEY S SANDMAIER BM TOROKSTORB B STORB R BUCKNER CD
Citation: Wi. Bensinger et al., TRANSPLANTATION OF ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS MOBILIZED BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR, Stem cells, 14(1), 1996, pp. 90-105
HIGH-DOSE THERAPY FOLLOWED BY AUTOLOGOUS HEMATOPOIETIC STEM-CELL INFUSION FOR PATIENTS WITH MULTIPLE-MYELOMA
Authors: BENSINGER WI ROWLEY SD DEMIRER T LILLEBY K SCHIFFMAN K CLIFT RA APPELBAUM FR FEFER A BARNETT T STORB R CHAUNCEY T MAZIARZ RT KLARNET J MCSWEENEY P HOLMBERG L MALONEY DG WEAVER CH BUCKNER CD
Citation: Wi. Bensinger et al., HIGH-DOSE THERAPY FOLLOWED BY AUTOLOGOUS HEMATOPOIETIC STEM-CELL INFUSION FOR PATIENTS WITH MULTIPLE-MYELOMA, Journal of clinical oncology, 14(5), 1996, pp. 1447-1456
ALLOGENEIC MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME WITH ADVANCED DISEASE MORPHOLOGY - A PHASE-II STUDY OF BUSULFAN, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION AND ANALYSIS OF PROGNOSTIC FACTORS
Authors: ANDERSON JE APPELBAUM FR SCHOCH G GOOLEY T ANASETTI C BENSINGER WI BRYANT E BUCKNER CD CHAUNCEY T CLIFT RA DEEG HJ DONEY K FLOWERS M HANSEN JA MARTIN PJ MATTHEWS DC NASH RA SANDERS JE SHULMAN H SULLIVAN KM WITHERSPOON RP STORB R
Citation: Je. Anderson et al., ALLOGENEIC MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME WITH ADVANCED DISEASE MORPHOLOGY - A PHASE-II STUDY OF BUSULFAN, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION AND ANALYSIS OF PROGNOSTIC FACTORS, Journal of clinical oncology, 14(1), 1996, pp. 220-226
HIGH-DOSE FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR TREATMENT OF MALIGNANT-LYMPHOMA - COMPARISON OF AUTOLOGOUS BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELLS
Authors: BRUNVAND MW BENSINGER WI SOLL E WEAVER CH ROWLEY SD APPELBAUM FR LILLEBY K CLIFT RA GOOLEY TA PRESS OW FEFER A STORB R SANDERS JE MARTIN PL CHAUNCEY T MAZIARZ RT ZUCKERMAN N MONTGOMERY P DORN R WEIDEN PL DEMIRER T HOLMBERG LA SCHIFFMAN K MCSWEENEY PA MALONEY DG BUCKNER CD
Citation: Mw. Brunvand et al., HIGH-DOSE FRACTIONATED TOTAL-BODY IRRADIATION, ETOPOSIDE AND CYCLOPHOSPHAMIDE FOR TREATMENT OF MALIGNANT-LYMPHOMA - COMPARISON OF AUTOLOGOUS BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELLS, Bone marrow transplantation, 18(1), 1996, pp. 131-141
PHASE-II STUDY OF HIGH-DOSE BUSULFAN, MELPHALAN AND THIOTEPA WITH AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL SUPPORT IN PATIENTS WITH MALIGNANT DISEASE
Authors: SCHIFFMAN KS BENSINGER WI APPELBAUM FR ROWLEY S LILLEBY K CLIFT RA WEAVER CH DEMIRER T SANDERS JE PETERSDORF S GOOLEY T WEIDEN P ZUCKERMAN N MONTGOMERY P MAZIARZ R KLARNET JP RIVKIN S TRUEBLOOD K STORB R HOLMBERG L BUCKNER CD
Citation: Ks. Schiffman et al., PHASE-II STUDY OF HIGH-DOSE BUSULFAN, MELPHALAN AND THIOTEPA WITH AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL SUPPORT IN PATIENTS WITH MALIGNANT DISEASE, Bone marrow transplantation, 17(6), 1996, pp. 943-950
MARROW TRANSPLANTATION FOR CML - THE SEATTLE EXPERIENCE
Authors: CLIFT RA STORB R
Citation: Ra. Clift et R. Storb, MARROW TRANSPLANTATION FOR CML - THE SEATTLE EXPERIENCE, Bone marrow transplantation, 17, 1996, pp. 1-3
MARROW TRANSPLANTATION FOR PATIENTS WITH THALASSEMIA - RESULTS IN CLASS 3 PATIENTS
Authors: LUCARELLI G CLIFT RA GALIMBERTI M POLCHI P ANGELUCCI E BARONCIANI D GIARDINI C ANDREANI M MANNA M NESCI S AGOSTINELLI F RAPA S RIPALTI M ALBERTINI F
Citation: G. Lucarelli et al., MARROW TRANSPLANTATION FOR PATIENTS WITH THALASSEMIA - RESULTS IN CLASS 3 PATIENTS, Blood, 87(5), 1996, pp. 2082-2088
ALLOGENEIC MARROW TRANSPLANTATION FOR REFRACTORY-ANEMIA - A COMPARISON OF 2 PREPARATIVE REGIMENS AND ANALYSIS OF PROGNOSTIC FACTORS
Authors: ANDERSON JE APPELBAUM FR SCHOCH G GOOLEY T ANASETTI C BENSINGER WI BRYANT E BUCKNER CD CHAUNCEY TR CLIFT RA DONEY K FLOWERS M HANSEN JA MARTIN PJ MATTHEWS DC SANDERS JE SHULMAN H SULLIVAN KM WITHERSPOON RP STORB R
Citation: Je. Anderson et al., ALLOGENEIC MARROW TRANSPLANTATION FOR REFRACTORY-ANEMIA - A COMPARISON OF 2 PREPARATIVE REGIMENS AND ANALYSIS OF PROGNOSTIC FACTORS, Blood, 87(1), 1996, pp. 51-58
HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOID MALIGNANCIES WHO HAD RECEIVED PRIOR DOSE-LIMITING RADIATION-THERAPY
Authors: DEMIRER T WEAVER CH BUCKNER CD PETERSEN FB BENSINGER WI SANDERS J CLIFT RA LILLEBY K ANASETTI C MARTIN P STORB R CHAUNCEY T DONEY K SULLIVAN K APPELBAUM FR
Citation: T. Demirer et al., HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE FOLLOWED BY ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH LYMPHOID MALIGNANCIES WHO HAD RECEIVED PRIOR DOSE-LIMITING RADIATION-THERAPY, Journal of clinical oncology, 13(3), 1995, pp. 596-602
PHASE-II STUDY OF BUSULFAN, CYCLOPHOSPHAMIDE AND FRACTIONATED TOTAL-BODY IRRADIATION AS A PREPARATORY REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH ADVANCED MYELOID MALIGNANCIES
Authors: LYNCH MHE PETERSEN FB APPELBAUM FR BENSINGER WI CLIFT RA STORB R SANDERS JE HANSEN JA BUCKNER CD
Citation: Mhe. Lynch et al., PHASE-II STUDY OF BUSULFAN, CYCLOPHOSPHAMIDE AND FRACTIONATED TOTAL-BODY IRRADIATION AS A PREPARATORY REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WITH ADVANCED MYELOID MALIGNANCIES, Bone marrow transplantation, 15(1), 1995, pp. 59-64
A RETROSPECTIVE ANALYSIS OF THE LONG-TERM EFFECT OF SPLENECTOMY ON LATE INFECTIONS, GRAFT-VERSUS-HOST DISEASE, RELAPSE, AND SURVIVAL AFTER ALLOGENEIC MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: KALHS P SCHWARZINGER I ANDERSON G MORI M CLIFT RA STORB R BUCKNER CD APPELBAUM FR HANSEN JA SULLIVAN KM
Citation: P. Kalhs et al., A RETROSPECTIVE ANALYSIS OF THE LONG-TERM EFFECT OF SPLENECTOMY ON LATE INFECTIONS, GRAFT-VERSUS-HOST DISEASE, RELAPSE, AND SURVIVAL AFTER ALLOGENEIC MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, Blood, 86(5), 1995, pp. 2028-2032
RELEVANCE OF MARROW FIBROSIS IN BONE-MARROW TRANSPLANTATION - A RETROSPECTIVE ANALYSIS OF ENGRAFTMENT
Authors: SOLL E MASSUMOTO C CLIFT RA BUCKNER CD APPELBAUM FR STORB R SALE G HACKMAN R MARTIN P
Citation: E. Soll et al., RELEVANCE OF MARROW FIBROSIS IN BONE-MARROW TRANSPLANTATION - A RETROSPECTIVE ANALYSIS OF ENGRAFTMENT, Blood, 86(12), 1995, pp. 4667-4673
THE INFLUENCE OF PATIENT AGE ON THE OUTCOME OF TRANSPLANTATION DURINGCHRONIC PHASE (CP) OF CHRONIC MYELOID-LEUKEMIA (CML)
Authors: CLIFT RA BUCKNER CD STORB R APPELBAUM FR THOMAS ED
Citation: Ra. Clift et al., THE INFLUENCE OF PATIENT AGE ON THE OUTCOME OF TRANSPLANTATION DURINGCHRONIC PHASE (CP) OF CHRONIC MYELOID-LEUKEMIA (CML), Blood, 86(10), 1995, pp. 2457-2457
POLYMERASE CHAIN-REACTION DETECTION OF THE BCR-ABL FUSION TRANSCRIPT AFTER ALLOGENEIC MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA -RESULTS AND IMPLICATIONS IN 346 PATIENTS
Authors: RADICH JP GEHLY G GOOLEY T BRYANT E CLIFT RA COLLINS S EDMANDS S KIRK J LEE A KESSLER P SCHOCH G BUCKNER CD SULLIVAN KM APPELBAUM FR THOMAS ED
Citation: Jp. Radich et al., POLYMERASE CHAIN-REACTION DETECTION OF THE BCR-ABL FUSION TRANSCRIPT AFTER ALLOGENEIC MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA -RESULTS AND IMPLICATIONS IN 346 PATIENTS, Blood, 85(9), 1995, pp. 2632-2638
EFFECT OF GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS ON RELAPSE IN PATIENTS TRANSPLANTED FOR ACUTE MYELOID-LEUKEMIA
Authors: WEAVER CH CLIFT RA DEEG HJ STORB R APPELBAUM FR BENSINGER W DONEY K HANSEN JA MARTIN PO SANDERS J SULLIVAN KM THOMAS ED SINGER J WITHERSPOON R BUCKNER CD
Citation: Ch. Weaver et al., EFFECT OF GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS ON RELAPSE IN PATIENTS TRANSPLANTED FOR ACUTE MYELOID-LEUKEMIA, Bone marrow transplantation, 14(6), 1994, pp. 885-893
MARROW TRANSPLANTS FROM UNRELATED DONORS
Authors: HANSEN JA ANASETTI C PETERSDORF E CLIFT RA MARTIN PJ
Citation: Ja. Hansen et al., MARROW TRANSPLANTS FROM UNRELATED DONORS, Transplantation proceedings, 26(3), 1994, pp. 1710-1712
MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - A RANDOMIZED STUDY COMPARING CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE
Authors: CLIFT RA BUCKNER CD THOMAS ED BENSINGER WI BOWDEN R BRYANT E DEEG HJ DONEY KC FISHER LD HANSEN JA MARTIN P MCDONALD GB SANDERS JE SCHOCH G SINGER J STORB R SULLIVAN KM WITHERSPOON RP APPELBAUM FR
Citation: Ra. Clift et al., MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - A RANDOMIZED STUDY COMPARING CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION WITH BUSULFAN AND CYCLOPHOSPHAMIDE, Blood, 84(6), 1994, pp. 2036-2043
MARROW TRANSPLANTATION FOR PATIENTS IN ACCELERATED PHASE OF CHRONIC MYELOID-LEUKEMIA
Authors: CLIFT RA BUCKNER CD THOMAS ED BRYANT E ANASETTI C BENSINGER WI BOWDEN R DEEG HJ DONEY KC FISHER LD HANSEN JA MARTIN P MCDONALD GB SANDERS JE SCHOCH G SINGER J STORB R SULLIVAN KM WITHERSPOON RP APPELBAUM FR
Citation: Ra. Clift et al., MARROW TRANSPLANTATION FOR PATIENTS IN ACCELERATED PHASE OF CHRONIC MYELOID-LEUKEMIA, Blood, 84(12), 1994, pp. 4368-4373
Risultati: 1-25 | 26-37